Abstract
As eukaryotic cells, protozoa present a classical structural organization where most of the structures and organelles typical of mammalian cells are found. However, even for usual organelles these organisms present structural diversity. In addition, some of the protozoa structures, such as the mitochondria, peroxisomes and even the Golgi complex, are not observed. On the other hand, new organelles such as the hydrogenosomes, mitosomes, Apicoplast, kinetoplast, glycosomes (specialized peroxisomes), rhoptries, micronemes and dense granules, are characteristic features of some protozoa. Also, several unusual cytoskeletal structures, some of them made of yet uncharacterized proteins, are seen in these eukaryotic microorganisms. Further characterization of these structures indicates that they contain special enzymes involved in distinct metabolic pathways making them potential targets for the development of new anti parasite drugs.
Keywords: Parasitic protozoa, structural organization
Current Pharmaceutical Design
Title: An Introduction to the Structural Organization of Parasitic Protozoa
Volume: 14 Issue: 9
Author(s): Wanderley de Souza
Affiliation:
Keywords: Parasitic protozoa, structural organization
Abstract: As eukaryotic cells, protozoa present a classical structural organization where most of the structures and organelles typical of mammalian cells are found. However, even for usual organelles these organisms present structural diversity. In addition, some of the protozoa structures, such as the mitochondria, peroxisomes and even the Golgi complex, are not observed. On the other hand, new organelles such as the hydrogenosomes, mitosomes, Apicoplast, kinetoplast, glycosomes (specialized peroxisomes), rhoptries, micronemes and dense granules, are characteristic features of some protozoa. Also, several unusual cytoskeletal structures, some of them made of yet uncharacterized proteins, are seen in these eukaryotic microorganisms. Further characterization of these structures indicates that they contain special enzymes involved in distinct metabolic pathways making them potential targets for the development of new anti parasite drugs.
Export Options
About this article
Cite this article as:
Souza de Wanderley, An Introduction to the Structural Organization of Parasitic Protozoa, Current Pharmaceutical Design 2008; 14(9) . https://dx.doi.org/10.2174/138161208784041123
DOI https://dx.doi.org/10.2174/138161208784041123 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Effects of Verbascoside Administration on the Blood Parameters and Oxidative Status in Jennies and Their Suckling Foals: Potential Improvement of Milk for Human Use
Endocrine, Metabolic & Immune Disorders - Drug Targets Influence of Hormones on Sjögren’s Syndrome
Current Pharmaceutical Design Nanocarriers For Drug Delivery: Mini Review
Current Nanomedicine More Effective DPP4 Inhibitors as Antidiabetics Based on Sitagliptin Applied QSAR and Clinical Methods
Current Computer-Aided Drug Design Antidepressants, β-Arrestins and GRKs: From Regulation of Signal Desensitization to Intracellular Multifunctional Adaptor Functions
Current Pharmaceutical Design VIP as a Potential Therapeutic Agent in Gram Negative Sepsis
Endocrine, Metabolic & Immune Disorders - Drug Targets Antioxidant Therapy and Drugs Interfering with Lipid Metabolism: Could They Be Effective in NAFLD Patients?
Current Pharmaceutical Design Emerging Roles of Perivascular Adipose Tissue in Regulation of Vascular Functions
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The Effects of Incretins on Energy Homeostasis: Physiology and Implications for the Treatment of Type 2 Diabetes Mellitus and Obesity
Current Vascular Pharmacology A Novel Marine Drug, SZ–685C, Induces Apoptosis of MMQ Pituitary Tumor Cells by Downregulating miR–200c
Current Medicinal Chemistry Treating Hypertension in the Elderly: Common Problems and Solutions
Current Hypertension Reviews Role of Cellular Elements in Thrombus Formation and Dissolution
Cardiovascular & Hematological Agents in Medicinal Chemistry A New Era of Pulmonary Delivery of Nano-antimicrobial Therapeutics to Treat Chronic Pulmonary Infections
Current Pharmaceutical Design Pregnancy-Associated Plasma Protein-A and its Role in Cardiovascular Disease. Biology, Experimental/Clinical Evidences and Potential Therapeutic Approaches
Current Vascular Pharmacology The Clinical Pharmacology of Short Acting Analgo-Sedatives in Neonates
Current Clinical Pharmacology Female Sexual Dysfunction: Therapeutic Options and Experimental Challenges
Cardiovascular & Hematological Agents in Medicinal Chemistry Editorial [Hot Topic: Nutritional Modulation of Autoimmune Diabetes (Guest Editor: Fraser W. Scott)]
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The Impact of Substance P on the Pathogenesis of Insulin Resistance Leading to Gestational Diabetes
Current Pharmaceutical Biotechnology Cardiovascular and Metabolic Effects of Ghrelin
Current Diabetes Reviews Update on Medical and Surgical Management of Intracerebral Hemorrhage
Reviews on Recent Clinical Trials